Literature DB >> 10024577

Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid.

M W Riggs1, M R McNeil, L E Perryman, A L Stone, M S Scherman, R M O'Connor.   

Abstract

The protozoan parasite Cryptosporidium parvum is an important cause of diarrhea in humans, calves, and other mammals worldwide. No approved vaccines or parasite-specific drugs are currently available for the control of cryptosporidiosis. To effectively immunize against C. parvum, identification and characterization of protective antigens are required. We previously identified CPS-500, a conserved, neutralization-sensitive antigen of C. parvum sporozoites and merozoites defined by monoclonal antibody 18.44. In the present study, the biochemical characteristics and subcellular location of CPS-500 were determined. CPS-500 was chloroform extractable and eluted with acetone and methanol in silicic acid chromatography, consistent with being a polar glycolipid. Following chloroform extraction and silicic acid chromatography, CPS-500 was isolated by high-pressure liquid chromatography for glycosyl analysis, which indicated the presence of mannose and inositol. To identify which component of CPS-500 comprised the neutralization-sensitive epitope recognized by 18.44, the ability of the monoclonal antibody to bind CPS-500 treated with proteases, or with alpha- or beta-glycosidases, was determined. Monoclonal antibody 18.44 did not bind antigen treated with beta-D-mannosidase but did bind antigen treated with alpha-D-mannosidase, other alpha- or beta-glycosidases, or a panel of proteases. These data indicated that the target epitope was dependent on terminal beta-D-mannopyranosyl residues. By immunoelectron microscopy, 18.44 binding was localized to the pellicle and an intracytoplasmic tubulovesicular network in sporozoites. Monoclonal antibody 18.44 also bound to antigen deposited and released onto substrate over the course travelled by gliding sporozoites and merozoites. Surface localization, adhesion and release during locomotion, and neutralization sensitivity suggest that CPS-500 may be involved in motility and invasion processes of the infective zoite stages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024577      PMCID: PMC96463     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Cloning and expression of cDNA encoding an antigenic Cryptosporidium parvum protein.

Authors:  M C Jenkins; R Fayer
Journal:  Mol Biochem Parasitol       Date:  1995-04       Impact factor: 1.759

2.  Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation.

Authors:  M P Woodward; W W Young; R A Bloodgood
Journal:  J Immunol Methods       Date:  1985-04-08       Impact factor: 2.303

3.  Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients.

Authors:  M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1987-04       Impact factor: 1.276

4.  Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue culture cells.

Authors:  R Lumb; K Smith; P J O'Donoghue; J A Lanser
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

5.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes.

Authors:  L E Perryman; D P Jasmer; M W Riggs; S G Bohnet; T C McGuire; M J Arrowood
Journal:  Mol Biochem Parasitol       Date:  1996-10-01       Impact factor: 1.759

6.  Enteric lesions and diarrhea in gnotobiotic calves monoinfected with Cryptosporidium species.

Authors:  J Heine; J F Pohlenz; H W Moon; G N Woode
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

7.  Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colostrum.

Authors:  L E Perryman; M W Riggs; P H Mason; R Fayer
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Rhoptry organelles of the apicomplexa: Their role in host cell invasion and intracellular survival.

Authors:  T Y Sam-Yellowe
Journal:  Parasitol Today       Date:  1996-08

9.  A comparative study of lipid compositions of Cryptosporidium parvum (Apicomplexa) and Madin-Darby bovine kidney cells.

Authors:  R R Mitschler; R Welti; S J Upton
Journal:  J Eukaryot Microbiol       Date:  1994 Jan-Feb       Impact factor: 3.346

10.  An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials.

Authors:  R E Chambers; J R Clamp
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

View more
  8 in total

1.  Parasites and immunotherapy: with or against?

Authors:  Hossein Yousofi Darani; Morteza Yousefi; Marzieh Safari; Rasool Jafari
Journal:  J Parasit Dis       Date:  2014-08-31

2.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells.

Authors:  R C Langer; M W Riggs
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis.

Authors:  Michael W Riggs; Deborah A Schaefer; Sushila J Kapil; Lise Barley-Maloney; Lance E Perryman
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

5.  Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL.

Authors:  R C Langer; D A Schaefer; M W Riggs
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis.

Authors:  D A Schaefer; B A Auerbach-Dixon; M W Riggs
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

8.  Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.

Authors:  Makoto Matsubayashi; Isao Teramoto-Kimata; Shigehiko Uni; Hyun S Lillehoj; Haruo Matsuda; Masaru Furuya; Hiroyuki Tani; Kazumi Sasai
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.